Back

Renal dysfunction at admission identifies a more severe clinical phenotype but not worse mid-term outcomes in acute heart failure

28 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Novel risk tools in acute heart failure Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Miguel De La Serna Real De Asua

University Hospital Getafe, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
Ultrasonographic staging of cardiac damage in patients with acute heart failure
Doctor V. Anastasiou (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
In-hospital potassium changes and clinical outcomes in patients with acute decompensated heart failure
Doctor C. HUANG (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Inflammatory burden in acute heart failure: association of hsCRP with cardiac structure and function, lung ultrasound findings, and survival
Ms Z. Hassan Juma (DK)
Abstract Slides Video
Presentation thumbnail
Association of anemia with risk factors in acute heart failure: differences across etiologies and ejection fraction
Doctor A. Pena (Cali, CO)
Abstract Slides Video
Presentation thumbnail
Subclinical pulmonary congestion provides further risk stratification in heart failure patients at discharge
Miss T. Liu (Chengdu, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Novel risk tools in acute heart failure

The Event

Event poster

ESC Congress 2026

28 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Renal function as a cornerstone for risk stratification in acute heart failure
21 March 2026
thumbnail
Congress Presentation
Clinical, paraclinical, therapeutical features and outcomes of acute decompensated heart failure: a moroccan experience
29 June 2021
thumbnail
Congress Presentation
Renal dysfunction: a predictor of adverse outcomes in ACHD patients with acute decompensated heart failure
27 August 2022
thumbnail
Congress Presentation
Kidney dysfunction correlates with worse response to levosimendan treatment
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources